We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ACBM market cap is 6.3M. The company's latest EPS is USD -0.2643 and P/E is -0.38.
| Year End 31 December 2022 | 2019 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.35M | 194k | 688k | 1.2M | 659k |
| Operating Income | -442k | -75k | -131k | -7.69M | -15.87M |
| Net Income | -371k | -76k | -118k | -7.7M | -15.87M |
| Year End 31 December 2022 | 2019 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.07M | 932k | 998k | 761k | 687k |
| Total Liabilities | 195k | 134k | 312k | 117k | 201k |
| Total Equity | 874k | 798k | 686k | 644k | 486k |
| Year End 31 December 2022 | 2019 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 80k | 35k | -200k | 299k | -147k |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | -80k | -35k | 217k | -222k | 58k |
| Market Cap | 6.3M |
| Price to Earnings Ratio | -0.38 |
| Price to Sales Ratio | 9.09 |
| Price to Cash Ratio | 1,000 |
| Price to Book Ratio | 12.35 |
| Dividend Yield | - |
| Shares Outstanding | 60.04M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -96.72% |
| 52 Week High | 3.20 |
| 52 Week Low | 0.105 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Arco Biomedical Company Ltd (CE) |
| Address |
8275 south eastern las vegas, nevada 89123 |
| Website | https://www.acrobiomedicalco.com |
| Industry | amusement & rec svcs, nec (7999) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
